Abstract
SAT0243 Incidence of thromboembolic events in the tofacitinib rheumatoid arthritis, psoriasis, psoriatic arthritis and ulcerative colitis development programmes
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have